1-deoxynojirimycin has been researched along with Diabetes Mellitus in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (14.29) | 18.7374 |
| 1990's | 9 (42.86) | 18.2507 |
| 2000's | 4 (19.05) | 29.6817 |
| 2010's | 1 (4.76) | 24.3611 |
| 2020's | 4 (19.05) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, N; Peng, SM; Wang, QQ; Yi, WB; Zou, XQ | 1 |
| Natori, Y | 1 |
| Alssema, M; Blaak, EE; Dekker, JM; Denise Robertson, M; Dussort, P; Egli, L; Ruijgrok, C; Vinoy, S | 1 |
| Absalan, A; Akbari, M; Momeni, H; Salehi, A | 1 |
| Kaur, N; Kaur, P; Kumar, V; Nayak, SK; Sahu, SK; Wadhwa, P | 1 |
| Fuchigami, M; Fukaya, N; Goda, T; Jiuxin, Z; Kumazawa, T; Mochizuki, K; Tanaka, Y | 1 |
| Horowitz, M; Lee, A; Morley, JE; Patrick, P; Wishart, J | 1 |
| Goda, T; Komori, A; Kumazawa, T; Kuranuki, S; Makita, Y; Mochizuki, K; Suruga, K | 1 |
| Kruseman, AC; Sels, JP; Wolffenbuttel, BH | 1 |
| Reuser, AJ; Wisselaar, HA | 1 |
| DeBouno, JF; Michaelis, OE; Tulp, OL | 1 |
| Mooradian, AD; Thurman, JE | 1 |
| Axen, KV; Li, X; Sclafani, A | 1 |
| Baker, DE; Campbell, LK; Campbell, RK | 1 |
| Huijberts, MS; Sels, JP; Wolffenbuttel, BH | 1 |
| Dimitriadis, G; Raptis, S | 1 |
| DeBouno, JF; Michaelis, OE; Szepesi, B; Tulp, OL | 1 |
| Toeller, M | 1 |
| Federlin, K; Hillebrand, I; Laube, H | 1 |
| Gerard, J; Hillebrand, I; Lefèbvre, PJ | 1 |
| Luger, A; Röggla, G; Schernthaner, G; Schnack, C | 1 |
10 review(s) available for 1-deoxynojirimycin and Diabetes Mellitus
| Article | Year |
|---|---|
Synthesis, nitric oxide release, and α-glucosidase inhibition of nitric oxide donating apigenin and chrysin derivatives.
Topics: alpha-Glucosidases; Apigenin; Diabetes Complications; Diabetes Mellitus; Flavonoids; Humans; Hypoglycemic Agents; Molecular Structure; Nitric Oxide; Structure-Activity Relationship | 2014 |
[Synthesis of L-Iminofuranoses and Their Biological Evaluations].
Topics: 1-Deoxynojirimycin; alpha-Glucosidases; Animals; Diabetes Mellitus; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Imino Pyranoses; Structure-Activity Relationship | 2021 |
Effects of alpha-glucosidase-inhibiting drugs on acute postprandial glucose and insulin responses: a systematic review and meta-analysis.
Topics: 1-Deoxynojirimycin; Acarbose; Diabetes Mellitus; Glucose; Glycoside Hydrolase Inhibitors; Humans; Inositol; Insulin; Postprandial Period | 2021 |
Alpha-amylase as molecular target for treatment of diabetes mellitus: A comprehensive review.
Topics: 1-Deoxynojirimycin; Acarbose; alpha-Amylases; Benzofurans; Blood Glucose; Diabetes Mellitus; Drug Discovery; Flavonoids; Glycoside Hydrolase Inhibitors; Humans; Hydrazones; Hypoglycemic Agents; Indoles; Inositol; Oxadiazoles; Structure-Activity Relationship | 2021 |
An evaluation of the potential side-effects of alpha-glucosidase inhibitors used for the management of diabetes mellitus.
Topics: 1-Deoxynojirimycin; Acarbose; Administration, Oral; Animals; Blood Glucose; Carbohydrate Sequence; Contraindications; Diabetes Mellitus; Diabetic Nephropathies; Glucosamine; Glycogen; Glycogen Storage Disease; Glycoproteins; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Imino Pyranoses; Molecular Sequence Data; Sucrase-Isomaltase Complex; Trisaccharides | 1994 |
Drug therapy of postprandial hyperglycaemia.
Topics: 1-Deoxynojirimycin; Acarbose; Amyloid; Carbamates; Diabetes Mellitus; Enzyme Inhibitors; Glucosamine; Glyburide; Humans; Hyperglycemia; Hypoglycemic Agents; Imino Pyranoses; Inositol; Insulin; Insulin Lispro; Islet Amyloid Polypeptide; Piperidines; Postprandial Period; Trisaccharides | 1999 |
Miglitol: assessment of its role in the treatment of patients with diabetes mellitus.
Topics: 1-Deoxynojirimycin; Aged; Animals; Diabetes Mellitus; Drug Administration Schedule; Drug Interactions; Glucosamine; Glycated Hemoglobin; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Imino Pyranoses; Intestinal Absorption; Middle Aged; Randomized Controlled Trials as Topic | 2000 |
Miglitol, a new alpha-glucosidase inhibitor.
Topics: 1-Deoxynojirimycin; Animals; Clinical Trials as Topic; Diabetes Mellitus; Enzyme Inhibitors; Glucosamine; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Imino Pyranoses | 1999 |
alpha-Glucosidase inhibition in the treatment of diabetes mellitus.
Topics: 1-Deoxynojirimycin; Acarbose; Diabetes Mellitus; Glucosamine; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Imino Pyranoses; Reference Values; Trisaccharides | 1992 |
[Inhibitors of alpha-glucosidase].
Topics: 1-Deoxynojirimycin; Acarbose; Blood Glucose; Carbohydrate Metabolism; Clinical Trials as Topic; Diabetes Mellitus; Digestion; Glucosamine; Glycoside Hydrolase Inhibitors; Imino Pyranoses; Insulin; Triglycerides; Trisaccharides | 1991 |
4 trial(s) available for 1-deoxynojirimycin and Diabetes Mellitus
| Article | Year |
|---|---|
Hydro-alcoholic extract of
Topics: 1-Deoxynojirimycin; alpha-Glucosidases; Blood Glucose; Diabetes Mellitus; Fasting; Glucosidases; Glycated Hemoglobin; Humans; Morus; Plant Extracts; Plant Leaves; Polymers; Water | 2022 |
The effects of miglitol on glucagon-like peptide-1 secretion and appetite sensations in obese type 2 diabetics.
Topics: 1-Deoxynojirimycin; Adult; Aged; Appetite; Diabetes Mellitus; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucosamine; Humans; Hypoglycemic Agents; Imino Pyranoses; Middle Aged; Obesity; Peptide Fragments; Postprandial Period; Protein Precursors | 2002 |
Assessment of the clinical efficacy and tolerance of two new alpha-glucosidase inhibitors in insulin-treated diabetics.
Topics: 1-Deoxynojirimycin; Adult; Blood Glucose; Body Weight; Diabetes Mellitus; Drug Tolerance; Fatty Acids, Nonesterified; Female; Glucosamine; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Imino Pyranoses; Insulin; Male; Middle Aged | 1987 |
Effects of the alpha-glucosidase inhibitor 1 desoxynojirimycin (Bay m 1099) on postprandial blood glucose, serum insulin and C-peptide levels in type II diabetic patients.
Topics: 1-Deoxynojirimycin; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Double-Blind Method; Eating; Female; Glucosamine; Glycoside Hydrolase Inhibitors; Humans; Imino Pyranoses; Insulin; Male; Middle Aged; Obesity; Pancreatic Hormones | 1986 |
7 other study(ies) available for 1-deoxynojirimycin and Diabetes Mellitus
| Article | Year |
|---|---|
The alpha-glucosidase inhibitor miglitol delays the development of diabetes and dysfunctional insulin secretion in pancreatic beta-cells in OLETF rats.
Topics: 1-Deoxynojirimycin; alpha-Glucosidases; Animals; Diabetes Mellitus; Glucose Tolerance Test; Glycoside Hydrolase Inhibitors; Hypoglycemic Agents; Insulin; Insulin Secretion; Insulin-Secreting Cells; Male; Rats; Rats, Inbred OLETF | 2009 |
Effects of miglitol, an alpha-glucosidase inhibitor, on glycaemic status and histopathological changes in islets in non-obese, non-insulin-dependent diabetic Goto-Kakizaki rats.
Topics: 1-Deoxynojirimycin; Animals; Blood Glucose; Diabetes Mellitus; Hypoglycemic Agents; Imino Pyranoses; Islets of Langerhans; Male; Random Allocation; Rats; Rats, Wistar; Treatment Outcome | 2007 |
Alpha-glucosidase inhibitors in diabetes. Introduction.
Topics: 1-Deoxynojirimycin; Acarbose; Diabetes Mellitus; Diet, Diabetic; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Trisaccharides | 1994 |
The effects of the intestinal glucosidase inhibitory BAY M 1099 (miglitol) on glycemic status of obese-diabetic rats.
Topics: 1-Deoxynojirimycin; Animals; Blood Glucose; Body Weight; Diabetes Mellitus; Diabetes Mellitus, Type 2; Eating; Glucosamine; Glycoside Hydrolase Inhibitors; Imino Pyranoses; Male; Obesity; Rats; Rats, Inbred SHR | 1993 |
Miglitol (BAY m 1099) treatment of diabetic hypothalamic-dietary obese rats improves islet response to glucose.
Topics: 1-Deoxynojirimycin; Animal Feed; Animals; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 2; Disease Models, Animal; Female; Glucosamine; Glucose; Glycoside Hydrolase Inhibitors; Hypoglycemic Agents; Imino Pyranoses; Insulin; Insulin Secretion; Islets of Langerhans; Obesity; Rats; Rats, Sprague-Dawley; Ventromedial Hypothalamic Nucleus | 1999 |
The effects of low-dose Bay-m-1099 (Miglitol) on serum lipids and liver enzyme activity of obese and obese-diabetic corpulent rats.
Topics: 1-Deoxynojirimycin; Adipose Tissue; Animals; Blood Glucose; Blood Proteins; Diabetes Mellitus; Glucokinase; Glucosamine; Glucosephosphate Dehydrogenase; Glycoside Hydrolase Inhibitors; Imino Pyranoses; Insulin; Lipids; Liver; Obesity; Phenotype; Rats; Weight Gain | 1991 |
Effect of alpha-inhibitors on blood glucose and insulin levels.
Topics: 1-Deoxynojirimycin; Acarbose; Aged; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 2; Double-Blind Method; Glucosamine; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Imino Pyranoses; Insulin; Middle Aged; Obesity; Reference Values; Trisaccharides | 1988 |